Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,497 public trials 2,844 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, not recruiting

A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and Granulocyte Colony Stimulating Factor (G-CSF) as Compared to Placebo and G-CSF for the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Subjects With Multiple Myeloma (MM)

NCT03246529

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • University of Florida Gainesville, Florida, United States
  • University of Miami Miami, Florida, United States
  • Loyola University Medical Center Chicago, Illinois, United States
View all 18 locations
View Trial Details
Active, not recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia

NCT04812925

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Investigator Site 0010116 Bentonville, Arkansas, United States
  • Investigator site 0010045 Washington D.C., District of Columbia, United States
  • Investigator Site 0010062 Fort Wayne, Indiana, United States
  • Investigator site US0010042 Iowa City, Iowa, United States
View all 83 locations
View Trial Details
Active, not recruiting

Gene Transfer for Sickle Cell Disease

NCT03282656

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +9 more
Locations
  • UCLA - Mattel Children's Hospital Los Angeles, California, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet Versus Best Available Therapy to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis

NCT04468984

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
Locations
  • Ironwood Cancer & Res Ctr /ID# 222162 Chandler, Arizona, United States
  • Highlands Oncology Group, PA /ID# 221826 Springdale, Arkansas, United States
  • City of Hope /ID# 218996 Duarte, California, United States
  • Providence - St. Jude Medical Center /ID# 271382 Fullerton, California, United States
View all 229 locations
View Trial Details

Related conditions